U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. CDER, Division of Advisory Committee and Consultant Management
  1. CDER Offices and Divisions

CDER, Division of Advisory Committee and Consultant Management


Director

Byron Marshall, JD

Deputy Director

Vacant    

Project Specialists

Ashley Antoine
Asuntae Furlow

Regulatory Counsel

Nicholas Marsh, JD

Technical Information Specialists

LCDR Andy Duong

Office Manager

Vacant

Writer/Editor

Robin Spencer

Advisory Committee Management Branch

Branch Chief

LCDR Michael Gu          

Designated Federal Officer (DFO) Team Leaders

 

Designated Federal Officers (DFOs) for CDER Advisory Committees

Arthritis Advisory Committee
Jessica Seo, PharmD, MPH
AAC@fda.hhs.gov

Anesthetic and Analgesic Drug Products Advisory Committee
Joyce Frimpong, PharmD
AADPAC@fda.hhs.gov

Antimicrobial Drugs Advisory Committee
LCDR Michael Gu
AMDAC@fda.hhs.gov

Cardiovascular and Renal Drugs Advisory Committee
CDR LaToya Bonner, PharmD         
CRDAC@fda.hhs.gov

Dermatologic and Ophthalmic Drugs Advisory Committee
CDR LaToya Bonner, PharmD         
DODAC@fda.hhs.gov

Drug Safety and Risk Management Advisory Committee
LCDR Michael Gu
DSaRM@fda.hhs.gov

Endocrinologic and Metabolic Drugs Advisory Committee
CDR LaToya Bonner, PharmD         
EMDAC@fda.hhs.gov

Gastrointestinal Drugs Advisory Committee
Jessica Seo, PharmD, MPH         
GIDAC@fda.hhs.gov

Medical Imaging Drugs Advisory Committee
Takyiah Stevenson, PharmD         
MIDAC@fda.hhs.gov

Nonprescription Drugs Advisory Committee
LCDR Michael Gu
NDAC@fda.hhs.gov

Oncologic Drugs Advisory Committee
LCDR Michael Gu      
ODAC@fda.hhs.gov

Obstetrics, Reproductive and Urologic Drugs Advisory Committee
Joyce Frimpong, PharmD         
ORUDAC@fda.hhs.gov

Pulmonary-Allergy Drugs Advisory Committee
Takyiah Stevenson, PharmD         
PADAC@fda.hhs.gov

Pharmacy Compounding Advisory Committee
Takyiah Stevenson, PharmD         
PCAC@fda.hhs.gov

Peripheral and Central Nervous System Drugs Advisory Committee
Jessica Seo, PharmD, MPH         
PCNS@fda.hhs.gov

Psychopharmacologic Drugs Advisory Committee
Joyce Frimpong, PharmD         
PDAC@fda.hhs.gov

Pharmaceutical Science and Clinical Pharmacology Advisory Committee
LCDR Michael Gu       
PSCP@fda.hhs.gov

Conflict of Interest (COI) Management Branch

Branch Chief

Cynthia (Cindi) Abernethy

COI Team Leaders

Anh Vu
CDR Nicole Doan, PharmD

COI Project Specialist

Suprena Allen

COI Analysts

Kurtis Dawley, PharmD                   
Chloe Kim, PharmD          
Janie Kim, RPh          
Michelle Lo, PharmD          
Emilija Renke, PharmD          
Deborah Rhee, PharmD          
CDR Jeannie Skanchy, RPh          
Derrice Ward-Davis    




Back to Top